Literature DB >> 17105778

Measurement of physiological recovery from exacerbation of chronic obstructive pulmonary disease using within-breath forced oscillometry.

Martin K Johnson1, Malcolm Birch, Roger Carter, John Kinsella, Robin D Stevenson.   

Abstract

BACKGROUND: Within-breath reactance from forced oscillometry estimates resistance via its inspiratory component (X(rs,insp)) and flow limitation via its expiratory component (X(rs,exp)). AIM: To assess whether reactance can detect recovery from an exacerbation of chronic obstructive pulmonary disease (COPD).
METHOD: 39 subjects with a COPD exacerbation were assessed on three occasions over 6 weeks using post-bronchodilator forced oscillometry, arterial blood gases, spirometry including inspiratory capacity, symptoms and health-related quality of life (HRQOL).
RESULTS: Significant improvements were seen in all spirometric variables except the ratio of forced expiratory volume in 1 s (FEV(1)) to vital capacity, ranging in mean (SEM) size from 11.0 (2.2)% predicted for peak expiratory flow to 12.1 (2.3)% predicted for vital capacity at 6 weeks. There was an associated increase in arterial partial pressure of oxygen (PaO(2)). There were significant mean (SEM) increases in both X(rs,insp) and X(rs,exp) (27.4 (6.7)% and 37.1 (10.0)%, respectively) but no change in oscillometry resistance (R(rs)) values. Symptom scales and HRQOL scores improved. For most variables, the largest improvement occurred within the first week with spirometry having the best signal-to-noise ratio. Changes in symptoms and HRQOL correlated best with changes in FEV(1), PaO(2) and X(rs,insp).
CONCLUSIONS: The physiological changes seen following an exacerbation of COPD comprised both an improvement in operating lung volumes and a reduction in airway resistance. Given the ease with which forced oscillometry can be performed in these subjects, measurements of X(rs,insp) and X(rs,exp) could be useful for tracking recovery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17105778      PMCID: PMC2092458          DOI: 10.1136/thx.2006.061044

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  29 in total

1.  Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.

Authors:  L Davies; R M Angus; P M Calverley
Journal:  Lancet       Date:  1999-08-07       Impact factor: 79.321

2.  Use of reactance to estimate transpulmonary resistance.

Authors:  M K Johnson; M Birch; R Carter; J Kinsella; R D Stevenson
Journal:  Eur Respir J       Date:  2005-06       Impact factor: 16.671

3.  Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.

Authors:  T A Seemungal; G C Donaldson; A Bhowmik; D J Jeffries; J A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2000-05       Impact factor: 21.405

4.  Physiological changes during symptom recovery from moderate exacerbations of COPD.

Authors:  C M Parker; N Voduc; S D Aaron; K A Webb; D E O'Donnell
Journal:  Eur Respir J       Date:  2005-09       Impact factor: 16.671

5.  Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.

Authors:  P L Paggiaro; R Dahle; I Bakran; L Frith; K Hollingworth; J Efthimiou
Journal:  Lancet       Date:  1998-03-14       Impact factor: 79.321

Review 6.  Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.

Authors:  R R Wood-Baker; P G Gibson; M Hannay; E H Walters; J A E Walters
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

7.  Relation of FEV(1) to clinical outcomes during exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group.

Authors:  D E Niewoehner; D Collins; M L Erbland
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

8.  Time course of recovery of health status following an infective exacerbation of chronic bronchitis.

Authors:  S Spencer; P W Jones
Journal:  Thorax       Date:  2003-07       Impact factor: 9.139

9.  Psychophysical bases of perceived exertion.

Authors:  G A Borg
Journal:  Med Sci Sports Exerc       Date:  1982       Impact factor: 5.411

10.  Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease.

Authors:  C R McGavin; M Artvinli; H Naoe; G J McHardy
Journal:  Br Med J       Date:  1978-07-22
View more
  12 in total

1.  Total inspiratory and expiratory impedance in patients with severe chronic obstructive pulmonary disease.

Authors:  Karla Kristine Dames Silva; Agnaldo José Lopes; José Manoel Jansen; Pedro Lopes de Melo
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

Review 2.  Patient-reported outcome measures for chronic obstructive pulmonary disease : the exclusion of people with low literacy skills and learning disabilities.

Authors:  Deepa Jahagirdar; Thilo Kroll; Karen Ritchie; Sally Wyke
Journal:  Patient       Date:  2013       Impact factor: 3.883

3.  Expiratory flow limitation relates to symptoms during COPD exacerbations requiring hospital admission.

Authors:  Kanika Jetmalani; Sophie Timmins; Nathan J Brown; Chantale Diba; Norbert Berend; Cheryl M Salome; Fu-Qiang Wen; Peng Chen; Gregory G King; Claude S Farah
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-05-14

4.  Comparison of pulmonary function in patients with COPD, asthma-COPD overlap syndrome, and asthma with airflow limitation.

Authors:  Yoshiaki Kitaguchi; Masanori Yasuo; Masayuki Hanaoka
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-05-09

Review 5.  Small airways disease: time for a revisit?

Authors:  James A Stockley; Brendan G Cooper; Robert A Stockley; Elizabeth Sapey
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-08-07

6.  Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study.

Authors:  Takahiro Kamada; Masahiro Kaneko; Hiromi Tomioka
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-02-03

7.  Effects of combination therapy indacaterol/glycopyrronium versus tiotropium on moderate to severe COPD: evaluation of impulse oscillometry and exacerbation rate.

Authors:  Antonio Molino; Francesca Simioli; Anna Agnese Stanziola; Mauro Mormile; Maria Martino; Maria D'Amato
Journal:  Multidiscip Respir Med       Date:  2017-09-27

8.  Within-breath analysis of respiratory mechanics in asthmatic patients by forced oscillation.

Authors:  Juliana Veiga; Agnaldo José Lopes; José Manoel Jansen; Pedro Lopes de Melo
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

Review 9.  COPD exacerbations: defining their cause and prevention.

Authors:  Jadwiga A Wedzicha; Terence A R Seemungal
Journal:  Lancet       Date:  2007-09-01       Impact factor: 79.321

Review 10.  An overview of exacerbations of chronic obstructive pulmonary disease: Can tests of small airways' function guide diagnosis and management?

Authors:  Nowaf Y Alobaidi; James A Stockley; Robert A Stockley; Elizabeth Sapey
Journal:  Ann Thorac Med       Date:  2020-04-03       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.